Trisalus Life Sciences, Inc. (TLSI) — SEC Filings
Trisalus Life Sciences, Inc. (TLSI) — 1 SEC filings. Latest: 8-K (Apr 7, 2026). Includes 1 8-K.
View Trisalus Life Sciences, Inc. on SEC EDGAR
Overview
Trisalus Life Sciences, Inc. (TLSI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 7, 2026: TriSalus Life Sciences, Inc. announced on April 1, 2026, the appointment of Dr. Richard J. K. Smith as Chief Medical Officer. Dr. Smith brings extensive experience in surgical innovation and medical device development to the company. This appointment is effective immediately and is expected to drive
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Trisalus Life Sciences, Inc. is neutral.
Filing Type Overview
Trisalus Life Sciences, Inc. (TLSI) has filed 1 8-K with the SEC between Apr 2026.
Recent SEC Filings (1)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 7, 2026 | 8-K | TriSalus Life Sciences Appoints New Chief Medical Officer | low |
Risk Profile
Risk Assessment: Of TLSI's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Dr. Richard J. K. Smith
Top Tags
executive-appointment (1) · medical-devices (1) · personnel (1)
Frequently Asked Questions
What are the latest SEC filings for Trisalus Life Sciences, Inc. (TLSI)?
Trisalus Life Sciences, Inc. has 1 recent SEC filings from Apr 2026, including 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of TLSI filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Trisalus Life Sciences, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Trisalus Life Sciences, Inc. (TLSI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Trisalus Life Sciences, Inc.?
Financial highlights for Trisalus Life Sciences, Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for TLSI?
Investment thesis data for TLSI will be available once enriched filings are processed.
Who are the key executives at Trisalus Life Sciences, Inc.?
Key executives identified across Trisalus Life Sciences, Inc.'s filings include Dr. Richard J. K. Smith.
What are the main risk factors for Trisalus Life Sciences, Inc. stock?
Of TLSI's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Trisalus Life Sciences, Inc.?
Forward guidance and predictions for Trisalus Life Sciences, Inc. are extracted from SEC filings as they are enriched.